Skip to content

Clinical trials

Scleroderma, Systemic trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Scleroderma, Systemic Country / region: Canada Clear all

43 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20081
20092
20102
20111
20121
20131
20153
20161
20172
20184
20195
20201
20212
20222
20233
20242
20256
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed24
Recruiting8
Terminated4
Unknown status2
Not yet recruiting2
Withdrawn1
Enrolling by invitation1
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Lady Davis Institute9
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's4
Boehringer Ingelheim3
Actelion2
Hoffmann-La Roche2
United Therapeutics2
Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA1
Allogene Therapeutics1
Alpine Immune Sciences, Inc.1
AstraZeneca1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Scleroderma, Systemic43
Scleroderma, Diffuse22
Lupus Erythematosus, Systemic6
Lung Diseases, Interstitial5
Autoimmune Diseases4
Hypertension, Pulmonary3
Skin Diseases3
Arthritis, Rheumatoid2
Colitis, Ulcerative2
Connective Tissue Diseases2

Trials

Showing 1 to 25 of 43. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.